GLP-1 Drugs Linked to Reduced Acute Schizophrenia Episodes
Researchers found GLP-1 users had 24% fewer psychiatric hospital admissions and 29% fewer emergency mental-health visits, with the strongest link in patients who lost weight.
4 Articles
4 Articles
In a large study based on U.S. health records, people with schizophrenia who also took GLP-1 medicines for diabetes (known as weight loss pens) had fewer psychiatric relapses, indicating another potential benefit of these drugs. Patients who used GLP-1 had a 24% lower probability of being hospitalized in a psychiatric hospital compared to those who did not use these drugs, according to researchers.
Geelong – People with schizophrenia and type 2 diabetes may have to be treated less rarely for psychiatric conditions in a hospital or emergency room when receiving GLP-1-based medication. This is indicated by a new study in The Lancet Psychiatry (2026; DOI: 10.1016/S2215-0366(26)00276-2). Schizophrenia is associated with...
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
